Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 5Phase 2/3 1

Status

Recruiting 2Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2

Conditions

Clinical Stage I Gastric Cancer AJCC v8 2Urinary Bladder Neoplasms 1Prostate Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

pembrolizumab 519Specimen Handling 382Carboplatin 374Magnetic Resonance Spectroscopy 337Cisplatin 328Nivolumab 309Cyclophosphamide 296Radiotherapy 256Paclitaxel 256Gemcitabine 235Biopsy 234Bevacizumab 213Dexamethasone 169durvalumab 166Oxaliplatin 162Rituximab 158Capecitabine 157Fluorouracil 148venetoclax 147Docetaxel 146Etoposide 141atezolizumab 140Drug Therapy 140Doxorubicin 134Ipilimumab 130Prednisone 120Lenalidomide 119Radiosurgery 118Leucovorin 112fludarabine 108

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Lymph Node Excision × 1 year × Clear all
NCT05836584 2026-05-13

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
240 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT05581589 2026-04-27

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

University of Washington

Phase 2 Terminated
4 enrolled 13 charts
Genitourinary

Urinary Bladder Neoplasms

NCT07519486 2026-04-15

INS-ESCC-CT

Sichuan University

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07139951 2025-12-31

HORIZON

Mayo Clinic

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT04175431 2025-12-18

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

University of Washington

Phase 2 Recruiting
100 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡